Table 3 The Proportion of Patients at Each Injection Interval at 6, 12 and 18 months of Aflibercept Treatment
6 months (n = 20) | 12 months (n = 17) | 18 months (n = 17) | |
|---|---|---|---|
Treatment Interval | |||
4 weeks | 4 (20%) | 4 (23.5%) | |
6 weeks | 6 (30%) | 3 (17.6%) | 5 (29.4%) |
8 weeks | 10(50%) | 4 (23.5%) | 3 (17.6%) |
10 weeks | 0 (0%) | 4 (23.5%) | |
12 weeks | 6 (35.3%) | 5 (29.4%) | |